Stacie Young
San Diego, California, United States
2K followers
500+ connections
Activity
-
As we wrap the 2025 San Antonio Breast Cancer Symposium (SABCS), I’m proud of how Exact Sciences continues advancing predictive and prognostic…
As we wrap the 2025 San Antonio Breast Cancer Symposium (SABCS), I’m proud of how Exact Sciences continues advancing predictive and prognostic…
Liked by Stacie Young
-
⏳ We spend more of our lives waiting than we realize. Waiting for test results. Waiting for interview results. Waiting for decisions, approvals, next…
⏳ We spend more of our lives waiting than we realize. Waiting for test results. Waiting for interview results. Waiting for decisions, approvals, next…
Liked by Stacie Young
Volunteer Experience
-
Executive Committee Secretary; Board Member
KeyNote, Home of San Diego Youth Symphony
- Present 6 years 7 months
Arts and Culture
Serve as Secretary, Executive Committee and Board Member for the San Diego Youth Symphony, providing governance leadership, strategic planning, and fiduciary oversight.
Strengthened organizational sustainability through fundraising, donor engagement, and community partnerships.
Advanced the Symphony’s mission by championing equity in arts education and expanding access to music programs for underserved youth.
Publications
More activity by Stacie
-
Today marks the end of my internship in the BioMol Lab at Universidad Veritas, where I had the opportunity to strengthen my experience in molecular…
Today marks the end of my internship in the BioMol Lab at Universidad Veritas, where I had the opportunity to strengthen my experience in molecular…
Liked by Stacie Young
-
Hello friends and colleagues. It's been a while since I've posted. I have some exciting news. Since I retired last year, my idea for the next great…
Hello friends and colleagues. It's been a while since I've posted. I have some exciting news. Since I retired last year, my idea for the next great…
Liked by Stacie Young
-
Celebrating an incredible year at Exact Sciences with some holiday fun. I’m so proud of this team and the impact we continue to make for patients…
Celebrating an incredible year at Exact Sciences with some holiday fun. I’m so proud of this team and the impact we continue to make for patients…
Liked by Stacie Young
-
I'm excited to share that I've completed my Project Management Institute PMP certification! Thanks again to Joanna S. and others supporting the…
I'm excited to share that I've completed my Project Management Institute PMP certification! Thanks again to Joanna S. and others supporting the…
Liked by Stacie Young
-
Rolled up my sleeve today to support the Abbott and Big Ten We Give Blood drive. Donating blood is a small effort with a huge impact. Each donation…
Rolled up my sleeve today to support the Abbott and Big Ten We Give Blood drive. Donating blood is a small effort with a huge impact. Each donation…
Liked by Stacie Young
-
An often overlooked but hugely important aspect of leadership is your ripple effect. You don’t see it, but others do. It affects your reputation and…
An often overlooked but hugely important aspect of leadership is your ripple effect. You don’t see it, but others do. It affects your reputation and…
Liked by Stacie Young
-
Every manager brings a wave of leadership that doesn’t stop at their product, it ripples through their teams, their environment, and even their…
Every manager brings a wave of leadership that doesn’t stop at their product, it ripples through their teams, their environment, and even their…
Liked by Stacie Young
-
Delighted to serve another year as a Director of SABANY. Hope to have even more amazing events this year as we continue to build our community.…
Delighted to serve another year as a Director of SABANY. Hope to have even more amazing events this year as we continue to build our community.…
Liked by Stacie Young
-
“We can now detect low-VAF biomarkers through a next-generation sequencing assay and get the answers that oncologists and their patients need,”…
“We can now detect low-VAF biomarkers through a next-generation sequencing assay and get the answers that oncologists and their patients need,”…
Liked by Stacie Young
Other similar profiles
Explore more posts
-
Helix
📢 Partnership Announcement Helix is partnering with @Veracyte to expand access to clinically actionable genomic insights for patients with metastatic and high-risk localized prostate cancer. Through this collaboration, Helix’s whole-exome based hereditary cancer test will be available alongside Veracyte’s Decipher® Prostate test, enabling urologists to access both germline and transcriptomic insights through a single, integrated workflow. 💬 “By partnering with Veracyte, we’re expanding access to both germline and transcriptomic insights through a single clinical workflow, helping physicians align care with the latest clinical guidelines.” - James Lu, M.D., Ph.D., CEO and co-founder, Helix 🧬 Learn more in our blog: https://bit.ly/458IJwy 📄 Read the full press release: https://bit.ly/3H4lNp0 #PrecisionMedicine #Genomics #Oncology #ProstateCancer #Partnership #Helix
8 Comments -
Scipher Medicine
Scipher Medicine and Roivant Sciences today announced a strategic partnership to advance rheumatology drug discovery and development by integrating Scipher’s real-world clinical and genomic data insights into Roivant’s research and development efforts. This collaboration will leverage Scipher's unique data and intelligence derived from its PrismRA precision medicine diagnostic. Scipher's PrismRA test uses 19 genomic markers to identify patients who are unlikely to respond to specific rheumatoid arthritis therapies, enabling personalized treatment decisions. By integrating data and insights derived from the development and commercialization of PrismRA, Roivant will leverage a unique and powerful data asset to inform its drug development pipeline. Link: https://lnkd.in/eWUdP8Gz #PrecisionMedicine #AutoimmuneDisease #RheumatoidArthritis #RealWorldEvidence #ArtificialIntelligence
1 Comment -
ConcertAI
At the upcoming AACR meeting, AbbVie will present a study utilizing ConcertAI's Patient360® electronic health records (EHRs) combined with Caris Life Sciences' molecular data, focusing on immune-oncology (IO) responses in non-small cell lung cancer (NSCLC). Come by on Monday, April 28th, from 2:00 to 5:00 PM for this insightful presentation! The comprehensive analysis involves over 2,176 NSCLC patients and aims to explore the mechanisms behind IO resistance. The findings reveal that patients who respond to IO therapies experience improved survival rates and longer treatment durations. Additionally, the study identifies significant biomarkers and molecular patterns that differentiate long-term responders from those who exhibit resistance. This research exemplifies the potential of real-world data to advance insights into cancer therapy, offering promising avenues for improved treatment strategies. Read abstract: https://hubs.ly/Q03jMLgt0 #AACR2025 #CancerResearch #Immunotherapy
-
American Oncology Network
We're proud to announce that more than 40 American Oncology Network clinics across 18 states and Washington, D.C., are now offering bispecific T-cell engager (BiTE) therapies to community oncology patients. Read today's news release to learn how this groundbreaking immunotherapy is expanding treatment options for hard-to-treat cancers here: https://hubs.li/Q03y84z60 #CommunityOncology #BiTE #Immunotherapy
3 Comments -
Daiichi Sankyo US
Metastatic breast cancer is different. #mBC is more complex than early-stage #BreastCancer, requiring alternative treatment plans. Abderrahmane Laadem, MD, Head of Late-Stage Oncology Clinical Development and Peter Soonmo Kang, MD, VP, Head of Late-Stage Clinical Development discuss the nuances and how Daiichi Sankyo US is developing innovations that may change the treatment landscape for patients. 🔗 Read the blog post here: https://bit.ly/4kf19Ay #NationalCancerAwarenessMonth #BreastCancer
-
Emily Whitehead Foundation
Foundation Executive Director George Eastwood will be speaking at the upcoming ASGCT Policy Summit on September 25 in Washington D.C. in a session titled, “Addressing CGT Bottlenecks: Focus on Clinical Care.” Advanced cell and gene therapies (CGTs) are transforming lives, but many patients face barriers to access. Families shouldn’t have to navigate coverage gaps, reimbursement delays, or the complexity of site onboarding to receive life-saving treatment. This session will bring together hospital leaders, state innovators, and funders to discuss how to turn patient-side burdens like travel, time, technology, and long-term follow-ups into standard components of care. The discussion will also spotlight policy changes that can close coverage gaps, speed-up reimbursement, and make safe community delivery possible so access isn’t determined by geography or hospital size. By applying lessons from pediatric oncology to autoimmune and other emerging indications and by building sustainable state-level access models, we can prepare health systems for larger, more diverse patient populations. The Emily Whitehead Foundation is committed to supporting patients and caregivers affected by childhood disease and to advocate for all patients who can be treated with advanced therapies. Panelists include: Susan Matesanz, MD, Children's Hospital of Philadelphia George Eastwood, Executive Director, Emily Whitehead Foundation Jeff Wagner, PharmD, Texas Children's Hospital Andrew Campbell, MD, Children's National Hospital Geoffrey Lomax, DRPH, California Institute for Regenerative Medicine
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content